(Q39384500)

English

Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 September 2017

Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody (English)

1 reference

Europe PubMed Central

11 September 2017

Stefano A Pileri

9

object named as

Stefano A Pileri

1 reference

Europe PubMed Central

11 September 2017

author name string

Claudio Agostinelli

1

1 reference

Europe PubMed Central

11 September 2017

Jennifer C Paterson

2

1 reference

Europe PubMed Central

11 September 2017

Rajeev Gupta

3

1 reference

Europe PubMed Central

11 September 2017

Simona Righi

4

1 reference

Europe PubMed Central

11 September 2017

Federica Sandri

5

1 reference

Europe PubMed Central

11 September 2017

Pier P Piccaluga

6

1 reference

Europe PubMed Central

11 September 2017

Francesco Bacci

7

1 reference

Europe PubMed Central

11 September 2017

Elena Sabattini

8

1 reference

Europe PubMed Central

11 September 2017

Teresa Marafioti

10

1 reference

Europe PubMed Central

11 September 2017

publication date

6 March 2012

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

61

1 reference

Europe PubMed Central

11 September 2017

1

1 reference

Europe PubMed Central

11 September 2017

33-46

1 reference

Europe PubMed Central

11 September 2017

The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The LIM domain: from the cytoskeleton to the nucleus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

SCL assembles a multifactorial complex that determines glycophorin A expression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The Lim-only protein LMO2 acts as a positive regulator of erythroid differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Regulation of LMO2 mRNA and protein expression in erythroid differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Cluster analysis and display of genome-wide expression patterns

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The significance of LMO2 expression in the progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Progenitor migration to the thymus and T cell lineage commitment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The thymus under siege: Lmo2 induces precancerous stem cells in a mouse model of T-ALL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2012.04198.X

21 January 2018

Identifiers

10.1111/J.1365-2559.2012.04198.X

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39384500&oldid=1824540067"